EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Análisis de la supervivencia en un programa de trasplante pulmonar en alta altitud: conocimientos de un estudio observacional de la vida real

Fabio A Varón-Vega, Adriana Rincón, Eduardo Tuta-Quintero, Catalina González-Avilés, Leidy P Prada, Luis J Téllez

Cirugía y Cirujanos · 2025

DOI: 10.24875/ciru.24000076 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Cirugía y Cirujanos, 2025. Verfasst von Fabio A Varón-Vega und 5 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care and Lung transplantation Service, Fundación Neumológica Colombiana, Fundación Cardio Infantil, Bogotá. Hauptthemen laut MEDLINE: Lung Transplantation, Altitude.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Survival in lung transplantation (LT) may be influenced by recipient-related variables, donor factors, donor-recipient interaction, surgical approach, and medical center expertise. The objective of this study was to describe the sociodemographic, clinical characteristics, and survival of patients who have undergone LT.

Method

We conducted an observational analysis between 2014 and 2022. Survival was calculated using the Kaplan-Meier method at the 1st, 3rd, and 5th years of follow-up post-transplantation.

Results

We analyzed data from 50 subjects, of whom 56% (28/50) were men, with a median age of 54 years (interquartile range: 39-59). The unadjusted survival rates post lung transplantation were 81.4% at 12-months, 65.8% at 3-years, and 53.6% at 5-years. Excluding mortality attributed to COVID-19, survival rates were 78.2% at 12-months, 68.8% at 3-years, and 63.5% at 5-years. The survival of pulmonary fibrosis with a non-usual interstitial pneumonia (N-UIP) pattern was 85% at 1 year and 54% at 5 years, while pulmonary fibrosis with a usual interstitial pneumonia (UIP) pattern demonstrated a solid survival rate of 80% at 1 year and 60% at 5 years.

Conclusions

Patients with pulmonary fibrosis with a N-UIP pattern demonstrated superior survival after 1 year of follow-up, while those with pulmonary fibrosis with a UIP pattern described the highest survival at the 5th year. COVID-19 decreased long-term survival in transplant patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationAltitudeHumansMaleFemaleMiddle AgedAdultKaplan-Meier EstimateCOVID-19Survival RateSurvival AnalysisPulmonary Fibrosis

Stichwörter der Autor:innen

Alta altitudHigh altitudeLung transplantationSupervivenciaSurvivalTrasplante pulmonar

Autor:innen und Institutionen

  • Critical Care and Lung transplantation Service, Fundación Neumológica Colombiana, Fundación Cardio Infantil, Bogotá.
  • Critical Care Service, Fundación Neumológica Colombiana, Fundación Cardio Infantil, Bogotá.
  • Department of Internal Medicine, School of Medicine, Universidad de La Sabana, Chía.
  • Department of Internal Medicine, School of Medicine, Pontificia Universidad Javeriana, Bogotá.
  • Thoracic Surgery, La Cardio, Bogotá. Colombia.

Zitieren

APA

Varón-Vega, F. A., Rincón, A., Tuta-Quintero, E., González-Avilés, C., Prada, L. P., & Téllez, L. J. (2025). Análisis de la supervivencia en un programa de trasplante pulmonar en alta altitud: conocimientos de un estudio observacional de la vida real. Cirugía y Cirujanos. https://doi.org/10.24875/ciru.24000076

Vancouver

Varón-Vega FA, Rincón A, Tuta-Quintero E, González-Avilés C, Prada LP, Téllez LJ. Análisis de la supervivencia en un programa de trasplante pulmonar en alta altitud: conocimientos de un estudio observacional de la vida real. Cirugía y Cirujanos. 2025. doi:10.24875/ciru.24000076

BibTeX
@article{VarnVega2025,
  author = {Varón-Vega, Fabio A and Rincón, Adriana and Tuta-Quintero, Eduardo and González-Avilés, Catalina and Prada, Leidy P and Téllez, Luis J},
  title = {Análisis de la supervivencia en un programa de trasplante pulmonar en alta altitud: conocimientos de un estudio observacional de la vida real},
  journal = {Cirugía y Cirujanos},
  year = {2025},
  doi = {10.24875/ciru.24000076}
}
Kostenlos starten →